サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1507318

抗うつ薬の世界市場規模調査：製品別、うつ病性疾患別、地域別予測：2022-2032年

Global Antidepressant Drugs Market Size study, by Product by Depressive Disorder and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
抗うつ薬の世界市場規模調査：製品別、うつ病性疾患別、地域別予測：2022-2032年
出版日: 2024年07月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗うつ薬市場は、2023年に約170億米ドルと評価され、予測期間2024-2032年には3.0％以上の健全な成長率で成長すると予測されています。

抗うつ薬はうつ病の治療に使用される薬物の一種であり、持続的な悲しみの感情や、かつて楽しんでいた活動への興味の喪失を引き起こす疾患です。抗うつ薬は、不安障害や強迫性障害といった他の疾患にも有効です。さらに、心的外傷後ストレス障害（PTSD）、強迫性障害（OCD）、全般性不安障害など、さまざまな障害がこれらの薬で治療されます。慢性疼痛患者もこの薬で治療されます。処方抗うつ薬は、うつ病の第一選択治療として単独で、あるいは行動療法や身体活動と組み合わせて使用することができます。さらに、抗うつ薬の市場開発への投資の増加や、人々の間で病気の蔓延に対する認識が高まっていることが、世界の抗うつ薬市場に対する注目を集めています。

抗うつ薬の世界市場は、うつ病に関する意識の高まり、うつ病の有病率の増加、世界中のヘルスケア分野における研究開発活動の進展によって牽引されています。世界保健機関（WHO）によると、2021年には成人の約5％がうつ病と診断されます。抗うつ薬は、脳内の様々なホルモンや化学物質のバランスを維持します。さらに、強迫性障害、大うつ病性障害、全般性不安障害など、生命を脅かす疾患の有病率の上昇が、同マーケットの成長を牽引しています。さらに、老年人口の増加と抗うつ薬の市場開拓のための承認数の増加が、市場に新たな機会を生み出しています。しかし、薬剤に関連する副作用と厳格な規制遵守は、予測期間2024-2032の間に市場の全体的な需要を阻害しようとしています。

抗うつ薬の世界市場調査において考慮した主要地域には、アジア太平洋地域、北米、欧州、ラテンアメリカ、その他世界のその他の地域が含まれます。2023年、北米は、うつ病の有病率の上昇、医薬品承認数の増加、主要な市場企業の存在、同地域のヘルスケア部門における研究開発活動の開発および投資のためのイニシアチブの上昇により、収益の面で最大の地域市場でした。しかし、アジア太平洋地域は、精神障害の有病率の増加、うつ病に関する意識の高まり、医療費の増加、臨床試験数の増加などの要因により、予測期間2024年から2032年にかけて最も速い速度で発展することが期待されています。

目次

第1章 世界の抗うつ薬市場の定義と調査前提条件

  • 調査目的
  • 市場の定義
  • 調査前提条件
    • 包含と除外
    • 制限事項
    • 供給サイドの分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • 抗うつ薬の世界市場規模・予測（2022年～2032年）
  • 地域別概要
  • セグメント別概要
    • 製品別
    • うつ病性疾患別
  • 主要動向
  • 景気後退の影響
  • アナリストの結論・提言

第3章 抗うつ薬の世界市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 抗うつ薬の世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターのファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 抗うつ薬の世界市場規模・予測：製品別 2022-2032年

  • 三環系抗うつ薬
  • 選択的セロトニン再取り込み阻害薬
  • セロトニン・ノルエピネフリン再取り込み阻害薬
  • モノアミン酸化酵素阻害薬
  • セロトニン拮抗薬および再取り込み阻害薬
  • その他

第6章 抗うつ薬の世界市場規模・予測：うつ病性疾患別 2022-2032年

  • 大うつ病性障害
  • 強迫性障害
  • 全般性不安障害
  • パニック障害
  • その他

第7章 抗うつ薬の世界市場規模・予測：地域別 2022-2032年

  • 北米の抗うつ薬市場
    • 米国
      • 製品別、市場規模＆予測、2022-2032年
      • うつ病性疾患別、市場規模＆予測、2022-2032年
    • カナダの抗うつ薬市場
  • 欧州の抗うつ薬市場
    • 英国の抗うつ薬市場
    • ドイツの抗うつ薬市場
    • フランスの抗うつ薬市場
    • スペインの抗うつ薬市場
    • イタリアの抗うつ薬市場
    • その他欧州の抗うつ薬市場
  • アジア太平洋抗うつ薬市場
    • 中国の抗うつ薬市場
    • インドの抗うつ薬市場
    • 日本の抗うつ薬市場
    • オーストラリアの抗うつ薬市場
    • 韓国の抗うつ薬市場
    • その他アジア太平洋地域の抗うつ薬市場
  • ラテンアメリカの抗うつ薬市場
    • ブラジルの抗うつ薬市場
    • メキシコの抗うつ薬市場
    • その他ラテンアメリカの抗うつ薬市場
  • 中東・アフリカの抗うつ薬市場
    • サウジアラビアの抗うつ薬市場
    • 南アフリカの抗うつ薬市場
    • その他中東とアフリカの抗うつ薬市場

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Alkermes Plc
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • AbbVie Inc.
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline, Inc.
    • H. Lundbeck A/S
    • Merck KGAA
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.（Actavis Generics）
    • Takeda Pharmaceutical Limited Company

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1. Global Antidepressant Drugs market, report scope
  • TABLE 2. Global Antidepressant Drugs market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3. Global Antidepressant Drugs market estimates & forecasts by Product 2022-2032 (USD Billion)
  • TABLE 4. Global Antidepressant Drugs market estimates & forecasts by Depressive Disorder 2022-2032 (USD Billion)
  • TABLE 5. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 6. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15. U.S. Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 16. U.S. Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 17. U.S. Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 18. Canada Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 19. Canada Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 20. Canada Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 21. UK Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 22. UK Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 23. UK Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 24. Germany Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 25. Germany Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 26. Germany Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 27. France Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 28. France Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 29. France Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 30. Italy Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 31. Italy Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 32. Italy Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 33. Spain Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 34. Spain Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 35. Spain Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 36. RoE Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 37. RoE Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 38. RoE Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 39. China Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 40. China Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 41. China Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 42. India Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 43. India Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 44. India Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 45. Japan Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 46. Japan Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 47. Japan Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 48. Australia Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 49. Australia Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 50. Australia Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 51. South Korea Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 52. South Korea Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 53. South Korea Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 54.
  • TABLE 55. RoAPAC Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 56. RoAPAC Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 57. RoAPAC Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 58. Brazil Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 59. Brazil Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 60. Brazil Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 61. Mexico Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 62. Mexico Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 63. Mexico Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 64. RoLA Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 65. RoLA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 66. RoLA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 67. Saudi Arabia Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 68. Saudi Arabia Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69. Saudi Arabia Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 70. South Africa Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 71.
  • TABLE 72. South Africa Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 73. South Africa Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74. RoMEA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75. RoMEA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76. RoMEA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 77. List of secondary sources, used in the study of Global Antidepressant Drugs Market.
  • TABLE 78. List of primary sources, used in the study of Global Antidepressant Drugs Market.
  • TABLE 79. Years considered for the study.
  • TABLE 80. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Antidepressant Drugs market, research methodology
  • FIG 2. Global Antidepressant Drugs market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods.
  • FIG 4. Global Antidepressant Drugs market, key trends 2023
  • FIG 5. Global Antidepressant Drugs market, growth prospects 2022-2032
  • FIG 6. Global Antidepressant Drugs market, porters 5 force model
  • FIG 7. Global Antidepressant Drugs market, pestel analysis
  • FIG 8. Global Antidepressant Drugs market, value chain analysis
  • FIG 9. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
  • FIG 10. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
  • FIG 11. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
  • FIG 12. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
  • FIG 13. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
  • FIG 14. Global Antidepressant Drugs market, regional snapshot 2022 & 2032
  • FIG 15. North America Antidepressant Drugs market 2022 & 2032 (USD Billion)
  • FIG 16. Europe Antidepressant Drugs market 2022 & 2032 (USD Billion)
  • FIG 17. Asia pacific Antidepressant Drugs market 2022 & 2032 (USD Billion)
  • FIG 18. Latin America Antidepressant Drugs market 2022 & 2032 (USD Billion)
  • FIG 19. Middle East & Africa Antidepressant Drugs market 2022 & 2032 (USD Billion)
  • FIG 20. Global Antidepressant Drugs market, company market share analysis (2023)
目次

Global Antidepressant Drugs Market is valued approximately USD 17 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.0% over the forecast period 2024-2032. Antidepressants are a type of medication used to treat depression, a condition that causes persistent feelings of sadness and a loss of interest in activities you once enjoyed. They can also be helpful for other conditions such as anxiety and obsessive-compulsive disorder. Additionally, a variety of disorders, including post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and generalized anxiety disorder, are treated with these medications. Chronic pain sufferers are also treated with it. Prescription antidepressants can be used alone or in combination with behavioural therapy and physical activity as a first-line treatment for depression. Furthermore, rising investment in development of Antidepressant Drugs and rising awareness of disease prevalence among people are gaining attention towards Global Antidepressant Drugs Market.

The Global Antidepressant Drugs Market is driven by the rise in awareness regarding depression, increasing prevalence of depression, and advancements in research and development activities in the healthcare sector across the globe. According to the World Health Organization (WHO), in year 2021, around 5% of the adult are diagnose with depression. Antidepressant drugs maintain balance of various hormones and chemicals in the brain. Moreover, rising prevalence of life-threatening diseases such as obsessive-compulsive disorder, major depressive disorder generalized anxiety disorder is driving the marker growth. Moreover, rise in geriatric population and, increase in number of approvals for the development of antidepressant drugs is creating new opportunities to the market. However, side effects associated with drug and strict regulatory compliance is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Antidepressant Drugs market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market in terms of revenue owing to rising prevalence of depression disorder, increasing number of drug approval, presence of key market players, and rise in initiatives for the development and investment in R&D activities in the healthcare sector in region. However, Asia-Pacific is expected to register fastest growth owing to factors such as increase in prevalence of mental disorders, rise in awareness regarding depression, growth in health care expenditures, and increase in number of clinical trials are some factors which are expected to develop the region at the fastest rate over the forecast period 2024-2032.

Major market player included in this report are:

  • Alkermes Plc
  • AbbVie Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline, Inc.
  • H. Lundbeck A/S
  • Merck KGAA
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd. (Actavis Generics)
  • Takeda Pharmaceutical Limited Company

The detailed segments and sub-segment of the market are explained below:

By Product

  • Tricyclic Antidepressants
  • Selective Serotonin Reuptake Inhibitors
  • Serotonin Norepinephrine Reuptake Inhibitors
  • Monoamine Oxidase Inhibitors
  • Serotonin Antagonist and Reuptake Inhibitors
  • Others

By Depressive Disorders

  • Major Depressive Disorder
  • Obsessive-Compulsive Disorder
  • Generalized Anxiety Disorder
  • Panic Disorder
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Antidepressant Drugs Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Antidepressant Drugs Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Product
    • 2.3.2. By Depressive Disorder
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Antidepressant Drugs Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Antidepressant Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Antidepressant Drugs Market Size & Forecasts by Product 2022-2032

  • 5.1. Tricyclic Antidepressants
  • 5.2. Selective Serotonin Reuptake Inhibitors
  • 5.3. Serotonin Norepinephrine Reuptake Inhibitors
  • 5.4. Monoamine Oxidase Inhibitors
  • 5.5. Serotonin Antagonist and Reuptake Inhibitors
  • 5.6. Others

Chapter 6. Global Antidepressant Drugs Market Size & Forecasts by Depressive Disorder 2022-2032

  • 6.1. Major Depressive Disorder
  • 6.2. Obsessive-Compulsive Disorder
  • 6.3. Generalized Anxiety Disorder
  • 6.4. Panic Disorder
  • 6.5. Others

Chapter 7. Global Antidepressant Drugs Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Antidepressant Drugs Market
    • 7.1.1. U.S. Antidepressant Drugs Market
      • 7.1.1.1. Product breakdown size & forecasts, 2022-2032
      • 7.1.1.2. Depressive Disorder breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada Antidepressant Drugs Market
  • 7.2. Europe Antidepressant Drugs Market
    • 7.2.1. U.K. Antidepressant Drugs Market
    • 7.2.2. Germany Antidepressant Drugs Market
    • 7.2.3. France Antidepressant Drugs Market
    • 7.2.4. Spain Antidepressant Drugs Market
    • 7.2.5. Italy Antidepressant Drugs Market
    • 7.2.6. Rest of Europe Antidepressant Drugs Market
  • 7.3. Asia-Pacific Antidepressant Drugs Market
    • 7.3.1. China Antidepressant Drugs Market
    • 7.3.2. India Antidepressant Drugs Market
    • 7.3.3. Japan Antidepressant Drugs Market
    • 7.3.4. Australia Antidepressant Drugs Market
    • 7.3.5. South Korea Antidepressant Drugs Market
    • 7.3.6. Rest of Asia Pacific Antidepressant Drugs Market
  • 7.4. Latin America Antidepressant Drugs Market
    • 7.4.1. Brazil Antidepressant Drugs Market
    • 7.4.2. Mexico Antidepressant Drugs Market
    • 7.4.3. Rest of Latin America Antidepressant Drugs Market
  • 7.5. Middle East & Africa Antidepressant Drugs Market
    • 7.5.1. Saudi Arabia Antidepressant Drugs Market
    • 7.5.2. South Africa Antidepressant Drugs Market
    • 7.5.3. Rest of Middle East & Africa Antidepressant Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Alkermes Plc
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. AbbVie Inc.
    • 8.3.3. Eli Lilly and Company
    • 8.3.4. F. Hoffmann-La Roche Ltd.
    • 8.3.5. GlaxoSmithKline, Inc.
    • 8.3.6. H. Lundbeck A/S
    • 8.3.7. Merck KGAA
    • 8.3.8. Pfizer Inc.
    • 8.3.9. Teva Pharmaceutical Industries Ltd. (Actavis Generics)
    • 8.3.10. Takeda Pharmaceutical Limited Company

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes